Fritextsökning
Innehållstyper
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
A platform for dialogue
As a step towards connecting the life science industry in Denmark, Biologue was founded three years ago with 10 member companies. Today, the network has 40 memb...
-
New member to Active board
The Election Committee of Active Biotech proposes a very experienced financial sector executive to join the company board. Five existing members are also to be ...
-
Robotlabb som automatiserar allt
Transcriptic är ett nytt koncept och finns tillgängligt som en service. är ett robotiserat start-up företag som ska göra livet på labbet enklare för användaren.
-
Pfizer lays a chunky bid on Wyeth
The merger of two pharma giants is the largest industry deal so far this year. Pfizer will acquire Wyeth in a cash-and-stock transaction currently valued at app...
-
New NO product reduces diabetic pain
The Swedish medtech company Nolabs has announced that it has achieved an important milestone in the development of a new line of products.
-
Diamyds vd går till Index
Från och med april ska Peter Zerhouni leda forskningsbolaget, som bland annat utvecklar läkemedel mot inflammatoriska tarmsjukdomar.
-
Orexo stämmer Actavis
Uppsalabolaget har inlämnat en stämningsansökan mot Actavis för patentintrång avseende Abstral i USA.
-
Success fee to Bioinvent and partner
The cancer collaboration started last year. After successful technology transfer the two partner companies now receives 5 million euro from pharma giant Roche.
-
Första priset efter rekorddonationen
I maj 2016 donerade Bengt Sjöberg 2 miljarder kronor - en av de största donationerna i svensk historia. Nu delas det första priset i donationens namn ut. Sjöber...
-
Lundbeck divests companies
The company sells all shares in one listed company plus divests four small private equity funds, for a three-figured million sum.
-
GSK:s ebolavaccin får snabbspår i FDA
Nu inleder bolaget patientstudier i friska frivilliga.
-
De får högst forskningsbidrag av Vetenskapsrådet
Jan Nilsson, Leif Groop och Jonas Frisén ska driva de projekt som fick högst bidrag i årets bidragsutdelning inom medicin och hälsa.
-
Han tar rodret på Siemens Healthcare
Tomas Kramar är vd för det nya bolaget som även rekryterat en försäljningschef.
-
Trio goes in for high tech medicines
The Swedish drug discovery company Beactica announces fragment-based drug discovery research collaboration with GE Healthcare and the University of Uppsala.
-
Eli Lilly writes biotech fine history
The American biotech company Eli Lilly will pay US 1.415 billion to resolve allegations of off-label promotion of a dementia drug.
-
New faces in Pronova Biopharma team
The Norwegian company Pronova Biopharma has recently changed the management team structure.
-
Think outside the... brain
Riitta Hari from the Brain Research Unit at the Helsinki University of Technology has recently stated that the mind is more than just the brain.
-
Orion cuts 205 jobs
The Finnish company Orion has completed its statutory negotiations. By this, personnel will be reduced by about 205 in Finland.
-
Tre diagnostikbolag slås ihop
Almi Invest investerar i en svensk-finsk företagsfusion med målet att få fram produkter för snabbare och säkrare analyssvar i sjukvården.
-
Dry blood DNA storage on a matrix
Qiagen recently presented a method of dry blood sample storage as an alternative to storage in freezers.
-
Ambassador program makes MVA big in Japan
The first ambassadors of the Medicon Valley Ambassador Programme have only worked in each other's countries for six months. But they have already made a signifi...
-
Grant for development projects in Gothenburg
Seven research projects receive SEK 1 million to promote commercialization of early drug development and medical technology.
-
New tools to fight bacteria
Better guidelines for doctors, detailed patient journals, and national monitoring systems are some of the tools needed to combat the increasing problem of antib...
BREAKING